| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |